Menu

艾滋病抗病毒治疗新药绥美凯哪里有

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Developed by ViiV Healthcare (a joint venture of GSK and Pfizer), it was approved by the US FDA on August 27, 2014 for the treatment of human immunodeficiency virus (HIV). It has been approved for marketing in more than 50 countries or regions, and has been recommended by many European and American authoritative institutions as a first-line drug for newly treated HIV-infected patients. More and more HIV patients are benefiting from it.

Where can I buy Suimeikai, a new HIV antiviral treatment drug?

Suimeikai is basically available in countries where it has been approved for marketing. In January 2018, the drug was successfully approved for marketing in my country. Patients can buy it in some domestic hospitals or pharmacies. However, the price of the original medicine is relatively high, around $3,000 per box.

The launch of Suimeike in my country provides a new treatment option for domestic HIV patients. In clinical trials, Suimeike has a significantly higher virus-inhibiting effect, has fewer side effects, and rarely leads to discontinuation of treatment. Moreover, Suimeikai is an oral tablet, which is easy to use, reducing the patient's medication burden and improving the patient's compliance. The method of use of Suimeikai is to take one tablet orally once a day.

Existing research shows that one year (48 weeks) after HIV-infected patients were treated with Suimeikan, 93% of the infected patients had a negative viral load, and the drug was well tolerated during the treatment.

Although it has been approved for marketing in my country, many patients say they cannot afford long-term use because of the relatively high price of the drug. Therefore, we might as well choose Suimeikai to be launched in India. The effect is basically the same as the domestic original drug. Each box has 30 tablets and the price is around $900. Patients who are convenient to go abroad can go to a regular pharmacy in India to purchase it in person. If it is not convenient for them to go abroad, they can consult the Medical Partner Travel Overseas Medical Consulting Service Company for formal purchase methods.

Recommended related hot articles: /newsDetail/80759.html

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。